Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
2,161,346
-
Shares change
-
+780,498
-
Total reported value, excl. options
-
$10,589,000
-
Value change
-
+$3,771,911
-
Put/Call ratio
-
87%
-
Number of buys
-
25
-
Number of sells
-
-7
-
Price
-
$4.90
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q1 2016
44 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q1 2016.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,161,346 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1,004,327 shares), GEODE CAPITAL MANAGEMENT, LLC (179,549 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (137,255 shares), CREDIT SUISSE AG/ (102,927 shares), UBS Group AG (68,696 shares), MILLENNIUM MANAGEMENT LLC (62,188 shares), GOLDMAN SACHS GROUP INC (55,940 shares), Bank of New York Mellon Corp (54,594 shares), NORTHERN TRUST CORP (54,560 shares), and HIGHBRIDGE CAPITAL MANAGEMENT LLC (50,704 shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.